NCT06302699 2024-03-12
Detecting Minimal Residual Diseases (MRD) and Monitoring Clonal Evolution Using Ultrasensitive Chromosomal Aberrations Detection (UCAD) in Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Unknown
Clinical Trials
7 trialsNCT05697913 2024-03-06
Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation
Hospital Galdakao-Usansolo
Phase NA Unknown
NCT04309084 2023-02-16
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
Celularity Incorporated
Phase 1 Unknown
NCT05578625 2022-10-13
ctDNA Methylation Sequencing for Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Unknown
NCT05536700 2022-09-13
Using Mass Spectrometry (EasyM) Detecting Minimal Residual Disease (MRD) in Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Unknown
NCT03702088 2019-11-19
Place of the Hevylite Test in the Evaluation of MRD in Myeloma
University Hospital, Montpellier
Unknown
NCT04122092 2019-11-18
EUCADD
Shanghai Changzheng Hospital
Unknown